AGAlfonso Gutiérrez-Aguado

Alfonso Gutiérrez-Aguado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alfonso Gutiérrez-Aguado has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Análisis de costos directos entre las terapias de reemplazo renal en un hospital peruano

    by Luis Arellan-Bravo, Briam Benito-Condor, Alfonso Gutiérrez-Aguado

    Introducción: la enfermedad renal crónica (ERC) es un problema de salud pública en el Perú. El sistema de salud peruano invierte alrededor del 4% de su presupuesto total en financiar solo terapias de hemodiálisis. Objetivo: determinar la comparación de los costos directos entre las terapias de reemplazo renal (TRR). Materiales y métodos: estudio descriptivo de análisis de costos. Se evaluaron los costos de los pacientes en las tres diferentes TRR: trasplante renal, hemodiálisis, diálisis peritoneal de la Red Asistencial Junín del Seguro Social EsSalud. Se analizaron los datos de 213 pacientes. Se calcularon los costos medios. Los datos fueron tomados de la Unidad de Adquisiciones y Costos de la Red Asistencial Junín (RAJ) EsSalud desde el año 2016 al año 2021. Resultados: el trasplante renal en el primer año acarrea un costo de 70 680 soles (US$ 18 123,07), el cual disminuye con el paso de los años. Luego, a partir del segundo año de trasplante el costo anual medio es de US$ 6 000. La hemodiálisis conlleva un costo de 39 000 soles anuales (US$ 10 000) y la diálisis peritoneal 49 680 soles (US$ 12 738). A los cinco años, la diálisis peritoneal es más costosa, seguida de la hemodiálisis y, finalmente, el trasplante renal. Conclusiones: la diálisis peritoneal es la terapia más costosa, seguida de la hemodiálisis y luego el trasplante renal.


  • Open Access

    Ocrelizumab for the treatment of relapsing remitting multiple sclerosis: A cost effectiveness study in Peru

    by Alfonso Gutierrez-Aguado, Mariuccia Angeles-Donayre

    Background: This study examines the cost-effectiveness of Ocrelizumab, a treatment for relapsing-remitting multiple sclerosis (RRMS), in the Peruvian healthcare system. RRMS is a chronic autoimmune disease affecting the central nervous system, and its prevalence in Peru has been reported to be 9.12 cases per 100,000 inhabitants. Methods: A cohort multi-state Markov model was developed to simulate disease progression and evaluate the cost-effectiveness of Ocrelizumab compared to other treatment alternatives for RRMS. The model considered various health states, including relapse, disability progression, conversion to secondary-progressive MS, mortality, treatment effect waning, treatment withdrawal, and adverse events. Costs associated with medication, administration, monitoring, and adverse events were included. Quality-adjusted life years (QALYs) and life years (LYs) gained were analyzed using the EQ-5D-5L questionnaire. Results: In the base-case scenario, Ocrelizumab was found to be a cost-effective intervention, with a cost per QALY and LYs below the willingness-to-pay threshold. When compared to other treatment alternatives, Ocrelizumab was dominant, providing greater QALYs and LYs at a lower cost than Interferon, Natalizumab, Teriflunomide, and Alemtuzumab. However, Alemtuzumab had a higher cost but provided more QALYs and LYs than Ocrelizumab. Conclusions: Ocrelizumab was deemed cost-effective in the treatment of RRMS in Peru. It offered a favorable balance between cost and health outcomes, making it a compelling choice for RRMS management and resource allocation. The study's findings align with previous research highlighting the cost-effectiveness of Ocrelizumab in RRMS treatment across different healthcare systems. Limitations include the simplifications made in the model and the availability and accuracy of data sources used.

  • Open Access

    Estilos de vida en mujeres de 18 a 49 años con sobrepeso y obesidad del Perú: análisis de la ENDES 2018

    by Anny Fabiola Chiroque Juárez, Alfonso Gutiérrez-Aguado, Rubén Espinoza, Jhony A. De La Cruz-Vargas

    Objetivo: Determinar la asociación entre estilos de vida en mujeres de 18 a 49 años con sobrepeso y obesidad del Perú teniendo en cuenta ENDES 2018. Materiales y métodos: Es un estudio observacional, transversal, analítico, data secundaria de ENDES 2018. Análisis estadístico se usó SPSS 25, test de chi cuadrado, correlación de Pearson, y razón de prevalencia (RP) cruda y ajustado con intervalo de Confianza 95% mediante regresión de Poisson con varianza robusta. Resultados: La prevalencia de sobrepeso 41,4% y obesidad 22,7%. En el análisis multivariado, los factores sociodemográficos tienen asociación significativa con obesidad: área urbana (RPa: 2.24, IC95%: 1.591 - 3.173), índice de riqueza (Q2: RPa: 1.65, IC95%:1.14 - 2.40; Q3: RPa: 1.58, IC95%: 1.07-2.33; Q4: RPa: 1.48, IC95%:1.00 - 2.21; Q5: RPa: 2.08, IC95%:1.39 - 3.11) y estilos de vida como: consumo de frutas (RPa=0.79; IC 95%: 0.68 - 0.92); consumo de alcohol (RPa: 1.18, IC95%: 1.04 - 1.33; RPa: 1.20, IC95%:1.07 - 1.35); frecuencia de ver televisión (menos de una vez a la semana RPa: 2.23, IC95%: 1.08 - 4.57; al menos una vez a la semana RPa: 2.69; IC95%: 1.25 - 5.76 y casi todos los días RPa: 2.64, IC95%:1.29 - 5.39). Conclusión: Tanto para sobrepeso como obesidad se encontró asociación significativa con el índice de riqueza. Además, para obesidad se encontró que el consumo de frutas presenta un factor protector; en cambio, residir en área urbana, consumir bebidas alcohólicas y la frecuencia de ver televisión son factores de riesgo.


  • Open Access

    Socioeconomic characteristics and costs of rare and orphan diseases in Peru, 2019

    by Grecia Claussen Portocarrero, Alfonso Gutierrez Aguado

    Introduction: The rare and orphan diseases (ROD) constitute a current challenge due to the lack of investigation. Objective: Describe the socioeconomic characteristics of rare and orphan diseases (ROD) in Peru, 2019. Methods: Descriptive observational design. The information was obtained from FISSAL administrative records, and an intentional sample of 20 patients was taken to carry out the questionnaire on ROD. For the economic records, a review of the public budget of the MEF was made. The data analysis was descriptive and inferential. Results: There were 454 patients with a total of 49 ROD; of these, the most representative age groups were schoolchildren and young adults (18% each), and the most frequent diagnosis was Tetralogy of Fallot (22%). The questionnaire on ROD reports a median of 7 months in the delay of diagnosis and between 3 and 5 doctors were visited. Likewise, 30% considered that it generated a high to very high expense. It was calculated that the ROD budget constitutes 2.25% of the total budget for high-cost diseases. Likewise, the ROD budget was different between 2014 and 2019. Conclusions: The population with ROD in Peru is not large; however, it requires greater attention to access to health services and a greater budget allocation.


  • Open Access

    Rearrangement Of The Supply Of Health Services For Newborn Care In Metropolitan Lima In The IPRESS Of The Ministry Of Health, 2015-2019

    by Alfonso Gutierrez-Aguado, Seimer Escobedo Palza, José Manuel Luicho Sobrado, Miguel Angel Huamaní Contreras

  • Open Access

    Prenatal Factors Associated With Breach Of The Basic Vaccination Scheme In Under 5 Years Of Age

    by Trinidad L. Isidro Ríos, Alfonso Gutiérrez Aguado

    Objective: To determine the prenatal risk factors associated with the failure to comply with the basic vaccination scheme in children under 5 years of age, based on the Demographic and Family Health Survey (ENDES) of 2018. Materials and Methods: It is an observational, retrospective, analytical and transversal study. We study the sample of the National Demographic and Health Survey (ENDES) for 2018 that includes 18 104 children between 1 and 5 years with health card seen in the interview, finding the results in the INEI surveys. The files containing the vaccination scheme questionnaires are selected and the data processed with SPSS version 25. The statistical processing is analytical and descriptive, bivariate and multivariate with the help of STATA v16 and Excel 2016. Results: There was a final sample of 18,104 children between 1 to 5 years old in 2018. The multivariate analysis found the association of non-compliance with the vaccination schedule with the mother's age (p value = Conclusions: The prenatal risk factors associated with the failure to comply with the basic vaccination scheme in children under 5 years of age were maternal age, the number of inadequate prenatal check-ups and the pregnant woman who had not received the tetanus vaccine.


  • Open Access

    Economic impact on the quality of health services in the framework of the COVID-19 pandemic in Peru

    by Alfonso Gutierrez-Aguado, Mitsy Pinares-Bonnett, Walter Salazar-Panta, José Guerrero-Cruz


  • Open Access

    Competencias del médico residente como educador en una universidad privada del Perú

    by Jason Riveros-Ruiz, Alfonso Gutiérrez-Aguado, Lucy E. Correa-López, Jhony A. De la Cruz-Vargas


  • Open Access

    FINANCIAMIENTO EN LA CAPACITACIÓN DE LOS PROFESIONALES EN SALUD BAJO LA PERSPECTIVA DEL SECTOR PÚBLICO, 2016-2018

    by Seimer Escobedo Palza, Alfonso Gutiérrez Aguado, Mariuccia Angeles Donayre, Martha Gutiérrez Aguado

    Objective: To estimate the funding and unit cost in the long-term training of health professionals in Peru. Methods: A partial economic evaluation (cost analysis) was carried out from the perspective of the public financier. For financing, reports are shown by budget categories and budget programs of the health sector. Data was obtained through the Integrated System of Financial Administration of the Ministry of Economy and Finance (SIAF-MEF) between the years 2016 - 2018. In relation to the analysis The cost was estimated using the absorption costing methodology. The data was obtained from the Integrated System of Administrative Management (SIGA) - logistic module to obtain the prices of the inputs, the Computer Application of Human Resources of Public Servants (AIRHSP) for salaries of human resources. Results: Financing made by the country in relation to training is estimated at 27 million soles for 2016, and it is reduced to 20 million soles by 2018. The per capita cost for graduates was S /. 12 661 (USD 3 836) and for the specialization it was S /. 23 356 (USD 7 077). Conclusion: Financing in the formation of human resources in health is vital for the achievement of health objectives in Peru. However, there is a decrease in the budget allocated to training activities in the last 3 years. Objetivo: Estimar el financiamiento y costo unitario en la capacitación a largo plazo de los profesionales de salud en el Perú. Métodos: Se realizó una evaluación económica parcial (análisis de costos) desde la perspectiva del financiador público. Para el financiamiento se muestra reportes por categorías presupuestales y programas presupuestales del sector salud, los datos se obtuvieron a través del Sistema Integrado de Administración Financiera del Ministerio de Economía y finanzas (SIAF-MEF) entre los años 2016 – 2018. En relación al análisis de costo se estimó con la metodología de costeo por absorción. Los datos se obtuvieron del Sistema Integrado de gestión Administrativa (SIGA)- modulo logístico para obtener los precios de los insumosy del aplicativo Informático de Recursos Humanos de Servidores Públicos (AIRHSP) para los sueldos de los recursos humanos. Resultados: Financiamiento que hace el país en relación a capacitación se estima en 27 millones de soles para el año 2016, y se reduce a 20 millones de soles para el año 2018. El costo per cápita para diplomados fue de S/.12 661 (USD 3 836) y para la especialización fue de S/. 23 356 (USD 7 077). Conclusión: el financiamiento en la formación del recurso humano en salud es vital para el logro de los objetivos sanitarios en el Perú. Sin embargo existe una disminución del presupuesto destinado a actividades de capacitación en los últimos 3 años.